News (154)

Transcript : Redfin Corporation, Q1 2024 Earnings Call, May 07, 2024
Redfin Reports First Quarter 2024 Financial Results BU
Redfin : 2025 Proxy statement PU
Transcript : Redfin Corporation, Q4 2023 Earnings Call, Feb 27, 2024
Redfin Reports Fourth Quarter and Full Year 2023 Financial Results BU
Transcript : Redfin Corporation, Q3 2023 Earnings Call, Nov 02, 2023
Redfin Reports Third Quarter 2023 Financial Results BU
Shares of Elliman, other realtors fall after $1.78 billion broker commission verdict RE
Redfin Announces Redfin Max, a Game-Changing Pay Plan for Agents BU
Transcript : Redfin Corporation, Q2 2023 Earnings Call, Aug 03, 2023
Redfin Reports Second Quarter 2023 Financial Results BU
REDFIN CORP : Submission of Matters to a Vote of Security Holders (form 8-K) AQ
Transcript : Redfin Corporation, Q1 2023 Earnings Call, May 04, 2023
Redfin Reports First Quarter 2023 Financial Results BU
Transcript : Redfin Corporation, Q4 2022 Earnings Call, Feb 16, 2023
Redfin Reports Fourth Quarter and Full Year 2022 Financial Results BU
Transcript : Redfin Corporation, Q3 2022 Earnings Call, Nov 09, 2022
Redfin Reports Third Quarter 2022 Financial Results BU
REDFIN CORP : Costs Associated with Exit or Disposal Activities, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) AQ
Moderna, Inc. CEO Stéphane Bancel, Goldman Sachs Chairman and CEO David Solomon, U.S. Senator John Hickenlooper, Among 2022 Mentors for Jeff Ubben Posse Fellows Program AQ
Redfin : Reports Second Quarter 2022 Financial Results - Form 8-K PU
Redfin : Quarterly Report for Quarter Ending June 30, 2022 (Form 10-Q) PU
Transcript : Redfin Corporation, Q2 2022 Earnings Call, Aug 04, 2022
Redfin Reports Second Quarter 2022 Financial Results BU
Redfin to Present at Oppenheimer 25th Annual Technology, Internet & Communications Conference BU
Real estate brokers Compass, Redfin to cut jobs as housing market cools RE
REDFIN CORP : Costs Associated with Exit or Disposal Activities, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) AQ
Transcript : Redfin Corporation, Q1 2022 Earnings Call, May 05, 2022
Redfin Reports First Quarter 2022 Financial Results BU
Redfin Completes Acquisition of Bay Equity Home Loans for $137.8 Million BU
Redfin : Appoints Brad Singer to Board of Directors - Form 8-K PU
Redfin Appoints Brad Singer to Board of Directors BU
Redfin Launches Rental Search BU
Newly Listed Homes in Short Supply, Down 12% in January BU
Transcript : Redfin Corporation, Q4 2021 Earnings Call, Feb 17, 2022
Redfin : Reports Fourth Quarter and Full Year 2021 Financial Results - Form 8-K PU
Redfin Reports Fourth Quarter and Full Year 2021 Financial Results BU
Redfin : to Acquire Bay Equity Home Loans - Form 8-K PU
Redfin to Acquire Bay Equity Home Loans BU
NYAM and NYC Health Department Drive Health Equity Research Through Unique Collaboration GL
NYAM and NYC Health Department Drive Health Equity Research Through Unique Collaboration GL
Redfin Reports Third Quarter 2021 Financial Results - Form 8-K PU
Transcript : Redfin Corporation, Q3 2021 Earnings Call, Nov 04, 2021
Redfin Reports Third Quarter 2021 Financial Results PR
Opendoor Technologies : acquires Seattle startup Pro.com and Skylight, will shut both platforms down PU
1234NextSee all

Insiders

Picture Glenn Kelman
Glenn Kelman

Founder of Plumtree Software, Inc., Glenn Kelman currently is President, Chief Executive Officer & Director at Redfin Corp. Mr. Kelman previously held the position of Product Manager at Stanford Technology Group, Inc. and Vice President-Product Management & Marketing at Plumtree Software, Inc. He received an undergraduate degree from the University of California, Berkeley.


Picture Kelman Kenneth
Kelman Kenneth

Kelman Kenneth currently works at Fantom Technologies, Inc., as Chairman from 2010.


Picture Laura Kelman
Laura Kelman

Ms. Laura Kelman is a Principal at Wright, Johnston & Mackenzie LLP.



Picture Glenda B. Kelman
Glenda B. Kelman

Glenda B.
Kelman
has a career history that includes being the Chairman at Glens Falls Hospital, Inc.




Picture Ariella Kelman
Ariella Kelman

Ariella Kelman is currently the Chief Medical Officer at Biora Therapeutics, Inc. She received a doctorate degree from Tel-Aviv University.



No results for this search

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW